Title: Stem Cell Therapeutic and Research Reauthorization Act of 2019
Policy area: Health

Summary:
Stem Cell Therapeutic and Research Reauthorization Act of 2019  This bill modifies and reauthorizes through FY2024 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also reauthorizes through FY2024 the Stem Cell Therapeutic and Research Act of 2005, which provides for the collection and maintenance of new units of high-quality cord blood.
The bill requires the Advisory Council on Blood Stem Cell Transplantation to convene at least twice per calendar year.

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3520 Introduced in House (IH)]

<DOC>






116th CONGRESS
  1st Session
                                H. R. 3520

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and 
                          for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             June 26, 2019

Mr. Smith of New Jersey (for himself and Mr. Bilirakis) introduced the 
   following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and 
                          for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stem Cell Therapeutic and Research 
Reauthorization Act of 2019''.

SEC. 2. REAUTHORIZATION OF THE C.W. BILL YOUNG CELL TRANSPLANTATION 
              PROGRAM.

    (a) In General.--Section 379(d)(2)(B) of the Public Health Service 
Act (42 U.S.C. 274k(d)(2)(B)) is amended--
            (1) by striking ``including remote collection, consistent 
        with the inventory'' and inserting ``including collection, 
        consistent with the inventory''; and
            (2) by inserting ``including remote collection,'' before 
        ``consistent with the requirements''.
    (b) Advisory Council Meetings.--Subsection (a) of section 379 of 
the Public Health Service Act (42 U.S.C. 274k) is amended by adding at 
the end the following new paragraph:
            ``(7) The Secretary shall convene the Advisory Council at 
        least two times each calendar year.''.
    (c) Authorization of Appropriations.--Section 379B of the Public 
Health Service Act (42 U.S.C. 274m) is amended by striking 
``$33,000,000 for fiscal year 2015 and $30,000,000 for each of fiscal 
years 2016 through 2020'' and inserting ``$30,000,000 for each of 
fiscal years 2020 through 2024''.

SEC. 3. CORD BLOOD INVENTORY.

    Subsection (g) of section 2 of the Stem Cell Therapeutic and 
Research Act of 2005 (42 U.S.C. 274k note) is amended to read as 
follows:
    ``(g) Authorization of Appropriations.--To carry out this section, 
there is authorized to be appropriated $23,000,000 for each of fiscal 
years 2020 through 2024.''.
                                 <all>